Key facts

Feiten en cijfers van BMS in België
  • Our Belux head office is located in Braine-l'Alleud
  • BMS has been active in Belgium and Luxembourg for more than 40 years
  • Every day, our people work together to make a difference in the lives of patients suffering from serious diseases
  • Through more than 114 active clinical trials with more than 1,150 patients, we ensure that Belgian and Luxembourg patients have access to the most innovative new medicines
We continue to invest and develop our pipeline, and we are the leader in a number of new indications.

Historical overview of reimbursed medicines in Belgium 

BMS Worldwide

Update 2021

Chief Executive Officer:
Headquarters:
New York City
Business:
Biopharmaceuticals
Website:
NYSE Listing:
BMY
Net Global Sales:
$42.5 billion in 2020
R&D Investment:
$11.14 billion which included the discovery and development of new medicines for patients
Principal Locations:

BMS in Belgium

Update 2021

General Manager:
Sally Ann McNab
Local Headquarters:
Parc de l’Alliance
Avenue de Finlande 4
1420 Braine-l’Alleud
Key Therapeutic Areas:

Oncology

Hematology

Cardiovascular

Immunology